MARKET PULSE-Himax, BG Medicine, Rackspace, Walgreen, Carnival

Tue Mar 25, 2014 12:07pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks trimmed gains on Tuesday, with the Nasdaq turning negative. The Dow Jones industrial average was up 0.26 percent at 16,319.72, the S&P 500 was up 0.07 percent at 1,858.69 and the Nasdaq Composite was down 0.34 percent at 4,212.079.

** HIMAX TECHNOLOGIES INC, $11.33, -15.32 pct

Analysts at BofA Merrill Lynch downgraded the chipmaker's stock to "under perform" from "buy," saying they were concerned that Himax's Liquid Crystal on Silicon (LCoS) display technology may not be progressing fast enough to achieve their estimates.

The analysts wrote that though the management was positive on LCoS, challenges such as applications, costs, power and technology suggested that growth could be more in 2015 or 2016 versus the second half of this year.

** BG MEDICINE INC, $2.16, +27.06 pct

The drugmaker said an analysis of data from three large trials of heart failure patients showed that elevations of a protein in the blood, measured by its diagnostic test, predicted patients who would have to be rehospitalized within 30 days of a hospital stay.

The results, published in the American Heart Journal, showed that patients with elevated levels of the protein were re-admitted at nearly three times the rate of patients without higher levels of the protein.   Continued...